This case series examines viral suppression outcomes among patients with HIV with prior adherence challenges, treatment experience, and resistance initiating lenacapavir and cabotegravir.
No takes yet. Share an insight, caveat, or question.
Gistand et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: